#USA #Eli Lilly #New Canaan #FlyteHealth #obesity management

FlyteHealth Expands Direct Access to Obesity Management Medications

Introduction
In a groundbreaking announcement, FlyteHealth, a prominent entity in integrated cardio-kidney-metabolic care, has declared its intention to provide self-insured organizations with direct access to obesity management medications produced by Eli Lilly. This strategic move is part of FlyteHealth's ongoing commitment to help employers foster better health outcomes for their employees suffering from obesity.

A Critical Need in the Employer Market
Obesity is a pressing health issue impacting over 100 million Americans, and the demand for effective cardio-kidney-metabolic treatments is on the rise. However, employers are often faced with fragmented solutions and unclear financial implications when it comes to offering coverage for obesity management. FlyteHealth’s new model seeks to address these concerns by offering an integrated approach that combines access to specific Lilly medications with a proven clinical care framework aimed at improving health outcomes and long-term cost efficiency.

What Makes This Model Unique?
The newly introduced employer offering is built on FlyteHealth's established capabilities, which include:

• - AI-Driven Personalized Care Plans: Tailored clinical pathways that cater to individual health profiles.
• - Comprehensive Treatment Options: Managing not just obesity, but also related conditions such as hypertension, pre-diabetes, diabetes, and hyperlipidemia simultaneously.
• - Expert Clinical Team: Access to board-certified specialists including obesity medicine physicians, Nurse Practitioners (NPs), Registered Dietitians (RDs), and Community Health Workers (CHWs) ensures high-quality care delivery.
• - Integrated Lifestyle and Behavioral Support: Comprehensive pathways that address lifestyle changes necessary for sustained health improvement.
• - Data-Driven Outcomes: Reporting that outlines adherence rates, treatment outcomes, and associated costs based on independent analysis from Milliman, enhancing transparency for employers.

Leadership Insights
Cheryl Pegus, MD, CEO of FlyteHealth, emphasized the company’s mission by stating, “Our focus is on delivering technology-enabled clinical excellence at scale. We're striving to reduce care fragmentation while significantly improving both outcomes and the total cost of care. Combining direct access to transparent pricing with our proven care models will better equip employers and their members to achieve sustainable health solutions.”

Kevin Hern, Lilly’s Senior Vice President, echoed these sentiments, highlighting the shared commitment to support employee health despite the challenges employers face: “We are thrilled to collaborate with organizations willing to enhance access to obesity management medicines. Our mutual goal is to mitigate barriers and provide flexible, transparent solutions that benefit employers and their employees going forward.”

Evolving Science of Obesity
Contributing to the discussion, Dr. Louis Aronne, founder of FlyteHealth, noted that as the understanding of obesity develops, integrated models such as this one will facilitate the application of evidence-based practices at a larger scale, promoting better health throughout communities. The continuous advancement in the treatment of obesity is vital for ensuring that affected individuals receive comprehensive, coordinated care leading to long-term success.

About FlyteHealth
FlyteHealth specializes in delivering precision care focused on cardio-kidney-metabolic conditions, spanning obesity, diabetes, hypertension, hyperlipidemia, and their associated comorbidities. Utilizing AI-guided clinical intelligence, alongside a team of certified professionals, FlyteHealth promises increased engagement, adherence to treatment, and improved health outcomes while minimizing overall care costs. Their demonstrated success includes high medication adherence rates and clinically meaningful health improvements across various populations, substantiated by independent validation.

For more information on FlyteHealth's innovative care solutions, visit FlyteHealth.

Conclusion
As FlyteHealth embarks on this new venture, their innovative model aims to reshape the landscape of employee health care management for obesity, ultimately creating a positive ripple effect across American workplaces. This initiative not only emphasizes the importance of coordinated and comprehensive care but also highlights the role of employers in facilitating healthier communities.